TABLE 2.
Endline iron status biomarkers in Rwandan women, by intervention group (Fe-Bean or Control-Bean)1
Adjusted endline values after 18 wk | |||
---|---|---|---|
Fe-Bean (n = 61) | Control-Bean (n = 64) | Difference between groups | |
Hemoglobin, g/dL | 12.5 (12.3, 12.7) | 12.2 (12.0, 12.4) | 0.3 (0.0, 0.5)* |
Log ferritin, ln μg/L2 | 2.6 (2.5, 2.7) | 2.4 (2.3, 2.5) | 0.2 (0.0, 0.3)* |
sTfR, mg/L | 8.0 (7.5, 8.6) | 8.1 (7.6, 8.7) | −0.1, (−0.9, 0.7) |
Body iron, mg/kg | 0.5 (0.1, 0.9) | −0.1 (−0.6, 0.3) | 0.6 (0.0, 1.3)* |
Values are least-square means (95% CIs), from general linear models adjusted for baseline value as well as baseline and endline CRP and adjusted for multiple comparisons using the Tukey adjustment method. *Indicates a P value <0.05. Control-Bean, intervention arm receiving conventional beans; CRP, C-reactive protein; Fe-Bean, intervention arm receiving iron-biofortified beans; sTfR, soluble transferrin receptor.
Ferritin was log transformed. Least-square means (95% CI) for the untransformed model (for easier interpretation of the effect) were as follows: Fe-Bean, 15.1 μg/L (13.6, 16.7); Control-Bean, 12.3 μg/L (10.8, 13.7); difference between groups, 2.9 μg/L (0.7, 5.0).